Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 15 results:
Author Title Type [ Year] Filters: Author is Papadakis, Efstathios [Clear All Filters]
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis..
Hormones (Athens). 13(4), 519-31.
(2014). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014). Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome..
Endocr Pract. 20(6), 540-7.
(2014). Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Gynecol Endocrinol. 29(10), 926-30.
(2013). Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome..
Eur J Endocrinol. 168(2), 145-52.
(2013). The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome..
Eur J Endocrinol. 168(6), 871-7.
(2013). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome..
Hum Reprod. 28(3), 785-93.
(2013). The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require r.
Hormones (Athens). 12(2), 192-200.
(2013). Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility..
Endocrine. 44(3), 583-90.
(2013). Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome..
Gynecol Endocrinol. 29(3), 250-3.
(2013). Prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 78(4), 586-92.
(2013). Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study..
Hum Reprod. 27(2), 541-9.
(2012). Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome..
Hormones (Athens). 11(1), 77-85.
(2012). Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome..
Eur J Obstet Gynecol Reprod Biol. 163(2), 185-9.
(2012).